emeis Société anonyme

ENXTPA:EMEIS Stock Report

Market Cap: €1.9b

emeis Société anonyme Past Earnings Performance

Past criteria checks 0/6

emeis Société anonyme's earnings have been declining at an average annual rate of -12.1%, while the Healthcare industry saw earnings growing at 15.5% annually. Revenues have been growing at an average rate of 8.8% per year.

Key information

-12.1%

Earnings growth rate

-32.6%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate8.8%
Return on equity-24.1%
Net Margin-7.3%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Should You Think About Buying Orpea SA (EPA:ORP) Now?

May 23
Should You Think About Buying Orpea SA (EPA:ORP) Now?

Orpea (EPA:ORP) May Have Issues Allocating Its Capital

Apr 18
Orpea (EPA:ORP) May Have Issues Allocating Its Capital

Why Orpea SA (EPA:ORP) Could Be Worth Watching

Jan 03
Why Orpea SA (EPA:ORP) Could Be Worth Watching

Orpea (EPA:ORP) Could Be Struggling To Allocate Capital

Nov 24
Orpea (EPA:ORP) Could Be Struggling To Allocate Capital

Orpea (EPA:ORP) Seems To Be Using A Lot Of Debt

Oct 18
Orpea (EPA:ORP) Seems To Be Using A Lot Of Debt

Revenue & Expenses Breakdown

How emeis Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ENXTPA:EMEIS Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 245,636-41200
30 Sep 245,53352800
30 Jun 245,4301,46900
31 Mar 245,3141,41200
31 Dec 235,1981,35500
30 Sep 235,062-1,38700
30 Jun 234,926-4,12800
31 Mar 234,803-4,07800
31 Dec 224,681-4,02700
30 Sep 224,602-2,16700
30 Jun 224,524-30700
31 Mar 224,411-12100
31 Dec 214,2996500
30 Sep 214,19312700
30 Jun 214,08818900
31 Mar 214,00517500
31 Dec 203,92216000
30 Sep 203,86317600
30 Jun 203,80419200
31 Mar 203,77221300
31 Dec 193,74023400
30 Sep 193,66123100
30 Jun 193,58122700
31 Mar 193,50122400
31 Dec 183,42022000
30 Sep 183,35623000
30 Jun 183,29223900
31 Mar 183,21516400
31 Dec 173,1389000
30 Sep 173,06213300
30 Jun 172,98617600
31 Mar 172,91423500
31 Dec 162,84129400
30 Sep 162,74522000
30 Jun 162,65014700
31 Mar 162,52113700
31 Dec 152,39212700
30 Sep 152,28612800
30 Jun 152,18013000
31 Mar 152,06412600
31 Dec 141,94912100
30 Sep 141,83211200
30 Jun 141,71610300

Quality Earnings: EMEIS is currently unprofitable.

Growing Profit Margin: EMEIS is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: EMEIS is unprofitable, and losses have increased over the past 5 years at a rate of 12.1% per year.

Accelerating Growth: Unable to compare EMEIS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EMEIS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (16.7%).

Return on Equity

High ROE: EMEIS has a negative Return on Equity (-24.13%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 23:52
End of Day Share Price 2025/05/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

emeis Société anonyme is covered by 21 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lionel PellicerAlphaValue
Stéphan DubosqArkeon Finance
Beatrice AllenBerenberg